Google’s recent acquisition of Fitbit for US$2.1 billion has left many users worried the tech giant may soon have access to their most intimate health information, from the number of steps they take each day to their breathing patterns, sleep quality, or menstrual cycles.
Fitbit, founded in San Francisco in 2007, tracks the health data of 28 million users. In a blogpost following the acquisition on Friday, November 1, Fitbit claimed user data would not be sold or used for Google advertising. “Consumer trust is paramount to Fitbit. Strong privacy and security guidelines have been part of Fitbit’s DNA since day one, and this will not change,” the company said in a statement.
Still, dozens of Fitbit wearers complained on social media over the weekend about the Google takeover. “I tossed my Fitbit into the trash today,” one user tweeted. “I intend to sell my Fitbit and delete my account,” said another.
Google already keeps a trove of information on people, including location data, search history, and YouTube viewing history. The company also creates advertisement profiles of users based on information such as location, gender, age, hobbies, career, interests, relationship status, possible weight, and income.
Veronica KB Olsen, a research fellow at Cern in Geneva, said she immediately requested her data be deleted upon hearing news of the merger.
“I am usually careful about big tech companies gobbling up too much data, but especially Google,” she said. “I have a knee-jerk reaction to Google having any of my data. I try to opt out of most of the stuff they do.”
Full Content: Running Magazine
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Regulators Probe SES-Intelsat Deal, Seek Insight on Starlink’s Competitive Threat
May 12, 2025 by
CPI
Trump Removes Copyright and Library of Congress Leaders After AI Policy Rift
May 12, 2025 by
CPI
Delta, Korean Air Buy Into WestJet in Major Cross-Border Deal
May 12, 2025 by
CPI
Trump Targets Big Pharma With Tough New Drug Pricing Rules
May 12, 2025 by
CPI
Geradin Partners Expands London Team with New Partner Hire
May 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece